These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Gardasil: Introducing the new human papillomavirus vaccine. McLemore MR Clin J Oncol Nurs; 2006 Oct; 10(5):559-60. PubMed ID: 17063609 [TBL] [Abstract][Full Text] [Related]
4. Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18. Villa LL; Ault KA; Giuliano AR; Costa RL; Petta CA; Andrade RP; Brown DR; Ferenczy A; Harper DM; Koutsky LA; Kurman RJ; Lehtinen M; Malm C; Olsson SE; Ronnett BM; Skjeldestad FE; Steinwall M; Stoler MH; Wheeler CM; Taddeo FJ; Yu J; Lupinacci L; Railkar R; Marchese R; Esser MT; Bryan J; Jansen KU; Sings HL; Tamms GM; Saah AJ; Barr E Vaccine; 2006 Jul; 24(27-28):5571-83. PubMed ID: 16753240 [TBL] [Abstract][Full Text] [Related]
5. HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine. Joura EA; Kjaer SK; Wheeler CM; Sigurdsson K; Iversen OE; Hernandez-Avila M; Perez G; Brown DR; Koutsky LA; Tay EH; García P; Ault KA; Garland SM; Leodolter S; Olsson SE; Tang GW; Ferris DG; Paavonen J; Lehtinen M; Steben M; Bosch X; Dillner J; Kurman RJ; Majewski S; Muñoz N; Myers ER; Villa LL; Taddeo FJ; Roberts C; Tadesse A; Bryan J; Lupinacci LC; Giacoletti KE; Lu S; Vuocolo S; Hesley TM; Haupt RM; Barr E Vaccine; 2008 Dec; 26(52):6844-51. PubMed ID: 18930097 [TBL] [Abstract][Full Text] [Related]
6. Prevaccine era human papillomavirus types 6, 11, 16 and 18 seropositivity in the U.S.A., National Health and Nutrition Examination Surveys, 2003-2006. Introcaso CE; Dunne EF; Hariri S; Panicker G; Unger ER; Markowitz LE Sex Transm Infect; 2014 Sep; 90(6):505-8. PubMed ID: 24748563 [TBL] [Abstract][Full Text] [Related]
7. Population seroprevalence of human papillomavirus types 6, 11, 16, and 18 in men, women, and children in Australia. Newall AT; Brotherton JM; Quinn HE; McIntyre PB; Backhouse J; Gilbert L; Esser MT; Erick J; Bryan J; Formica N; MacIntyre CR Clin Infect Dis; 2008 Jun; 46(11):1647-55. PubMed ID: 18444790 [TBL] [Abstract][Full Text] [Related]
8. [Value of general human papillomavirus vaccination in sexually active women]. Hampl M Dtsch Med Wochenschr; 2009 Apr; 134 Suppl 2():S95-9. PubMed ID: 19353480 [TBL] [Abstract][Full Text] [Related]
10. The quadrivalent human papillomavirus vaccine. Wheat A Med Health R I; 2008 Dec; 91(12):387-9. PubMed ID: 19170317 [No Abstract] [Full Text] [Related]
11. Re: Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women. Brewer NT; Reiter PL J Natl Cancer Inst; 2010 Oct; 102(19):1517; author reply 1517-8. PubMed ID: 20811003 [No Abstract] [Full Text] [Related]
12. StatBite: Prevalence of HPV in a cohort of U.S. men. J Natl Cancer Inst; 2009 Feb; 101(4):223. PubMed ID: 19211451 [No Abstract] [Full Text] [Related]
16. Human papillomavirus and the HPV vaccine: are the benefits worth the risks? Knudtson M; Tiso S; Phillips S Nurs Clin North Am; 2009 Sep; 44(3):293-9. PubMed ID: 19683091 [TBL] [Abstract][Full Text] [Related]
17. Quadrivalent HPV vaccination reactions--more hype than harm. Douglas RJ Aust Fam Physician; 2009 Mar; 38(3):139-42. PubMed ID: 19283255 [TBL] [Abstract][Full Text] [Related]
18. HPV vaccines and pregnancy: the situation in early 2012. Prescrire Int; 2012 Jun; 21(128):154-7. PubMed ID: 22822594 [TBL] [Abstract][Full Text] [Related]
19. [Prophylactic vaccination against human papillomavirus]. Derancourt C Ann Dermatol Venereol; 2007 Nov; 134(11):882-5; quiz 881, 886. PubMed ID: 18033077 [No Abstract] [Full Text] [Related]